In active ulcerative colitis, risankizumab induced and maintained remission
- PMID: 39496179
- DOI: 10.7326/ANNALS-24-02768-JC
In active ulcerative colitis, risankizumab induced and maintained remission
Abstract
Louis E, Schreiber S, Panaccione R, et al; INSPIRE and COMMAND Study Group. Risankizumab for ulcerative colitis: two randomized clinical trials. JAMA. 2024;332:881-897. 39037800.
Conflict of interest statement
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical